9.83
Precedente Chiudi:
$9.68
Aprire:
$9.58
Volume 24 ore:
174.27K
Relative Volume:
0.64
Capitalizzazione di mercato:
$216.30M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-10.46
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+0.92%
1M Prestazione:
+11.07%
6M Prestazione:
+226.58%
1 anno Prestazione:
+233.22%
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
XGN
Exagen Inc
|
9.83 | 211.45M | 52.55M | -23.69M | -15.29M | -0.94 |
![]()
TMO
Thermo Fisher Scientific Inc
|
489.49 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
199.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
640.44 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
128.48 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
![]()
IQV
Iqvia Holdings Inc
|
184.08 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-30 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2025-07-23 | Iniziato | Craig Hallum | Buy |
2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-10-15 | Ripresa | Cowen | Outperform |
2021-04-15 | Iniziato | Canaccord Genuity | Buy |
2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
2020-10-08 | Iniziato | BTIG Research | Buy |
2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
2019-10-14 | Iniziato | Cowen | Outperform |
2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Using AI based signals to follow Exagen Inc.July 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
Intraday pattern recognizer results for Exagen Inc.Quarterly Market Review & Momentum Based Trading Signals - Newser
Exagen Inc. stock momentum explainedJuly 2025 Reactions & Consistent Income Trade Recommendations - Newser
Exagen Inc. stock trend forecast2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Real time pattern detection on Exagen Inc. stock2025 Trading Volume Trends & Daily Growth Stock Tips - Newser
Can Exagen Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - thegnnews.com
How to forecast Exagen Inc. trends using time series2025 Top Gainers & Community Verified Trade Signals - Newser
Tools to assess Exagen Inc.’s risk profile2025 Market Outlook & Expert Curated Trade Setups - Newser
Smart tools for monitoring Exagen Inc.’s price actionPortfolio Growth Summary & Expert Approved Momentum Ideas - Newser
Can technical indicators confirm Exagen Inc.’s reversalEarnings Summary Report & Daily Momentum Trading Reports - Newser
What’s the analyst consensus on Exagen Inc.July 2025 Sentiment & Verified Entry Point Detection - khodrobank.com
What the charts say about Exagen Inc. todayM&A Rumor & Community Trade Idea Sharing Platform - Newser
Is Exagen Inc. exposed to political risk2025 Dividend Review & Low Risk Investment Opportunities - khodrobank.com
Using R and stats models for Exagen Inc. forecastingExit Point & Entry Point Confirmation Signals - Newser
Volume spikes in Exagen Inc. stock – what they meanGap Up & Weekly Chart Analysis and Trade Guides - Newser
What risks could impact Exagen Inc. stock performance2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Will Exagen Inc. benefit from AI trendsJuly 2025 Outlook & Reliable Trade Execution Plans - khodrobank.com
Exagen Inc.’s Beta Climbs After Market Volatility getLinesFromResByArray error: size == 0 - 더경남뉴스
Is It Too Late to Sell Exagen Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Will Exagen Inc. price bounce be sustainableForecast Cut & AI Driven Stock Movement Reports - Newser
Fibonacci Retracement Aligns with Support in Exagen Inc.Market Growth Summary & AI Optimized Trading Strategy Guides - beatles.ru
Risk adjusted return profile for Exagen Inc. analyzedBuy Signal & Low Risk High Reward Ideas - Newser
Is Exagen Inc. stock reversal real or fakeMarket Activity Report & Safe Capital Allocation Plans - Newser
Market reaction to Exagen Inc.’s recent news2025 Biggest Moves & Safe Swing Trade Setups - Newser
How to use a screener to detect Exagen Inc. breakoutsJuly 2025 Action & AI Enhanced Trading Alerts - Newser
Comparing Exagen Inc. in custom built stock radarsTrend Reversal & Entry and Exit Point Strategies - Newser
Exagen Inc. stock daily chart insightsEarnings Beat & Reliable Trade Execution Plans - Newser
Multi Factor Analysis Ranks Exagen Inc. as Strong Buy getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Exagen Inc. reversing from oversold territoryJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Exagen Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
Is There Enough Volume to Lift Exagen Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Exagen Inc Azioni (XGN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):